Guo Tong Xu
Director/Board Member bij ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.
Profiel
Guo Tong Xu is on the board of Zhejiang Shapuaisi Pharmaceutical Co. Ltd., Guangzheng Eye Hospital Group Co., Ltd., PharmaLegacy Laboratories (Shanghai) Co., Ltd.
and Gracell Biotechnologies, Inc. and Professor at Tongji University.
In the past Dr. Xu occupied the position of Director-Stem Cell Bank at Temple University School of Medicine.
Dr. Xu received a doctorate from the University of North Texas Health Science Center, a doctorate from Peking Union Medical College, a doctorate from Chinese Academy of Medical Sciences and an undergraduate degree from Harbin Medical University.
Actieve functies van Guo Tong Xu
Bedrijven | Functie | Begin |
---|---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Director/Board Member | 28-08-2020 |
GUANGZHENG EYE HOSPITAL GROUP CO., LTD. | Director/Board Member | 01-06-2018 |
GRACELL BIOTECHNOLOGIES INC. | Director/Board Member | 01-02-2019 |
Tongji University | Corporate Officer/Principal | 01-01-2008 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Director/Board Member | 01-07-2022 |
Eerdere bekende functies van Guo Tong Xu
Bedrijven | Functie | Einde |
---|---|---|
CELLULAR BIOMEDICINE GROUP, INC. | Director/Board Member | 11-11-2016 |
Temple University School of Medicine | Corporate Officer/Principal | 01-07-2016 |
Opleiding van Guo Tong Xu
Harbin Medical University | Undergraduate Degree |
University of North Texas Health Science Center | Doctorate Degree |
Chinese Academy of Medical Sciences | Doctorate Degree |
Peking Union Medical College | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Health Technology |
GUANGZHENG EYE HOSPITAL GROUP CO., LTD. | Health Services |
Bedrijven in privébezit | 3 |
---|---|
AbelZeta Pharma, Inc.
AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
Gracell Biotechnologies, Inc.
Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China. | Health Technology |